Analyst Consensus ?
ConsensusHold48 ratings
Bullish2245.8%
Neutral2347.9%
Bearish36.3%
FN2 Earnings Intelligence
Huntington Bancshares Incorporated (HBAN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Jul 28, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 28, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Jul 27, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jul 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 24, 2026 |
| UBS | Buy | Buy | Maintain | Jul 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jul 6, 2026 |
| DA Davidson | Buy | Buy | Maintain | Mar 16, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jan 23, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jan 5, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Dec 19, 2025 |
| Piper Sandler | Underweight | Underweight | Maintain | Dec 10, 2025 |
| TD Cowen | Buy | Buy | Maintain | Oct 20, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 20, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 3, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 2, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 26, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 24, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 6, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Oct 25, 2019 |
| Macquarie | Underperform | Neutral | Downgrade | Jul 12, 2019 |
| Argus | Hold | Hold | Maintain | May 31, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Nov 29, 2018 |
| Hilliard Lyons | Buy | Neutral | Upgrade | Feb 9, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Sep 14, 2017 |
| JMP Securities | Perform | Market Perform | Maintain | Aug 31, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Aug 11, 2017 |
| FBR Capital | Market Perform | Outperform | Downgrade | Oct 11, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 6, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 6, 2016 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| CLSA | Underperform | Underperform | Maintain | Jul 8, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| Canaccord Genuity | Hold | Buy | Downgrade | May 11, 2015 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Apr 24, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Mar 9, 2015 |
| Portales Partners | Sector Perform | Underperform | Upgrade | Jul 21, 2014 |
| ISI Group | Neutral | Neutral | Maintain | Oct 7, 2013 |
| Compass Point | Neutral | Buy | Downgrade | Apr 18, 2013 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 19, 2012 |
| Bank oferica | Buy | Buy | Maintain | May 9, 2012 |
Upside is calculated against the persisted previous close $16.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $20 | $17.24 | +18.8% | Jul 28, 2026 |
| Robert W. Baird | David George | $21 | $17.4 | +24.7% | Jul 24, 2026 |
| Stephens | Analyst unavailable | $19 | $17.4 | +12.8% | Jul 24, 2026 |
| Jefferies | Analyst unavailable | $18 | $17.4 | +6.9% | Jul 23, 2026 |
| UBS | Analyst unavailable | $22 | $18.03 | +30.6% | Jul 7, 2026 |
| Evercore ISI | John Pancari | $21 | $17.76 | +24.7% | Jul 6, 2026 |
| Jefferies | Analyst unavailable | $19 | $17.86 | +12.8% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $21 | $17.81 | +24.7% | Jun 29, 2026 |
| Evercore ISI | Analyst unavailable | $20 | $17.21 | +18.8% | Jun 12, 2026 |
| Piper Sandler | Analyst unavailable | $18 | $16.62 | +6.9% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $20 | $16.12 | +18.8% | Mar 9, 2026 |
| UBS | Analyst unavailable | $21 | $19.08 | +24.7% | Feb 4, 2026 |
| National Bank | Manan Gosalia | $21 | $18.39 | +24.7% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $21 | $17.8 | +24.7% | Jan 12, 2026 |
| Wolfe Research | Analyst unavailable | $21 | $18.1 | +24.7% | Jan 7, 2026 |
| Goldman Sachs | Ryan Nash | $21 | $17.99 | +24.7% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $20 | $17.48 | +18.8% | Jan 5, 2026 |
| RBC Capital | Analyst unavailable | $20 | $17.62 | +18.8% | Dec 19, 2025 |
| Piper Sandler | Analyst unavailable | $16 | $17 | -5.0% | Dec 10, 2025 |
| Evercore ISI | John Pancari | $18 | $15.97 | +6.9% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $23 | $17.42 | +36.6% | Sep 29, 2025 |
| Argus Research | Kevin Heal | $17 | $14.46 | +1.0% | Apr 25, 2025 |
| Truist Financial | Brian Foran | $21 | $16.55 | +24.7% | Jan 21, 2025 |
| Citigroup | Keith Horowitz | $18 | $15.36 | +6.9% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $15 | $15.43 | -10.9% | Oct 18, 2024 |
| Morgan Stanley | Manan Gosalia | $18 | $13.75 | +6.9% | Aug 5, 2024 |
| Robert W. Baird | David George | $15 | $15.06 | -10.9% | Jul 26, 2024 |
| Argus Research | Kevin Heal | $16 | $15.01 | -5.0% | Jul 22, 2024 |
| RBC Capital | Jon Arfstrom | $17 | $14.86 | +1.0% | Jul 22, 2024 |
| Morgan Stanley | Manan Gosalia | $16 | $14.8 | -5.0% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $17.5 | $15.01 | +3.9% | Jul 22, 2024 |
| Stephens | Terry McEvoy | $16 | $15.01 | -5.0% | Jul 22, 2024 |
| Piper Sandler | Scott Siefers | $11.5 | $12.34 | -31.7% | Jun 14, 2024 |
| Piper Sandler | Scott Siefers | $13.5 | $12.77 | -19.8% | Jun 10, 2024 |
| Jefferies | Ken Usdin | $16 | $13.6 | -5.0% | Apr 8, 2024 |
| Stephens | Terry McEvoy | $15 | $13.95 | -10.9% | Apr 1, 2024 |
| UBS | Erika Naharian | $15 | $12.72 | -10.9% | Feb 14, 2024 |
| D.A. Davidson | Analyst unavailable | $15 | $14 | -10.9% | Dec 21, 2022 |
| J.P. Morgan | Analyst unavailable | $14.5 | $14.54 | -13.9% | Dec 13, 2022 |
| Morgan Stanley | Analyst unavailable | $19 | $15.46 | +12.8% | Dec 5, 2022 |
| Raymond James | Analyst unavailable | $18 | $14.1 | +6.9% | Apr 22, 2022 |
| RBC Capital | Jon Arfstrom | $19 | $15.03 | +12.8% | Jan 21, 2022 |
| Barclays | Jason Goldberg | $17 | $15.64 | +1.0% | Jan 3, 2022 |
| Stephens | Terry McEvoy | $17.5 | $15.55 | +3.9% | Nov 9, 2021 |
| Goldman Sachs | Ryan Nash | $18 | $14.27 | +6.9% | Aug 18, 2021 |
| KBW | David Konrad | $15 | $13.56 | -10.9% | Jul 6, 2021 |
Track every rating change on HBAN the moment it posts. Free to start.
Start free